| Literature DB >> 34800139 |
T Hamann1,2, M R J Wiest1,2, M Brinkmann1,2, M Toro1,2,3, K Fasler1,2, J Baur1,2, K B Freund4,5, Sandrine Zweifel6,7.
Abstract
PURPOSE: To investigate a possible microvascular component of poppers maculopathy (PMP) using optical coherence tomography angiography (OCTA).Entities:
Keywords: Drug toxicity; Multimodal imaging; OCT angiography; Poppers maculopathy; Retinal toxicity
Mesh:
Year: 2021 PMID: 34800139 PMCID: PMC8913571 DOI: 10.1007/s00417-021-05453-0
Source DB: PubMed Journal: Graefes Arch Clin Exp Ophthalmol ISSN: 0721-832X Impact factor: 3.117
Characteristics of poppers maculopathy (PMP) patients; extent of exposure to poppers and time from last exposure to examination are given as far as the information is available. Based on definition of PMP lesion phenotype by Van Bol et al. [4], 11 patients showed a disturbance of ellipsoid layer phenotype. In one patient, vitelliform lesion type was detected; in the majority of cases, visual acuity (VA) increased over the course of follow-up; one patient had a history of previous bilateral optic neuritis
| ID | Age (a)/sex | OCTA | Duration/frequency of exposition upon first consultation | Time from first symptoms to examination | Time from exposure to examination | Phenotype of PMP | Follow-up duration | Termination of poppers use | Continuous EZ in follow-up | Initial VA OD; OS | Last VA OS; OS | Remarks |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P01 | 39/m | Yes | Unknown/once per week | 2 weeks | 3 days | Disturbance of ellipsoid layer | 1 months | Yes | Yes | 20/20; 20/20 | 20/20; 20/20 | Discontinuation of poppers use between follow-ups |
| P02 | 41/m | Yes | Four months/once or twice per week | 2 days | 3 days | Disturbance of ellipsoid layer | 40 months | No, reduced to once per month | No | 20/32; 20/32 | 20/32; 20/32 | History of repeated affection of VA after poppers application |
| P03 | 42/m | No | 15 years/2–3 × per month | 7 days | 8 days | Disturbance of ellipsoid layer | 40 months | No | Yes | 20/20; 20/32 | 20/20; 20/25 | Known amblyopia of the left eye |
| P04 | 23/m | Yes | 4 to 5 years/once per week | 1 day | 9 days | Disturbance of ellipsoid layer | 3 months | Yes | Yes | 20/25; 20/32 | 20/20; 20/20 | None |
| P05 | 47/m | Yes | Unknown/unknown | 6 years | 2 months | Disturbance of ellipsoid layer | 2 months | Yes | No | 20/32; 20/32 | 20/32; 20/32 | History of repeated affection of VA after poppers application |
| P06 | 64/m | Yes | 40 years/once per week | No symptoms | One week | Vitelliform | None | No | n.a | 20/20; 20/32 | n.a.; n.a | Subjective affection of VA by sildenafil |
| P07 | 45/m | Yes | 10 years/once peer week | No symptoms | One week | Disturbance of ellipsoid layer | None | No | n.a | 20/20; 20/20 | n.a.; n.a | None |
| P08 | 35/m | Yes | Unknown/unknown | Unknown | 3–4 days | Disturbance of ellipsoid layer | 6 months | Unknown | Yes | 20/32; 20/25 | 20/25; 20/20 | Status after bilateral optic neuritis* |
| P09 | 24/m | Yes | Unknown/unknown | 5 days | 6 days | Disturbance of ellipsoid layer | 1 week | Unknown | No | 20/32; 20/25 | 20/32; 20/25 | None |
| P10 | 38/m | Yes | 10 to 15 years/once per week | 6 months | 2.5 months | Disturbance of ellipsoid layer | 6 months | Yes | Subtotal | 20/30; 20/25 | 20/25; 20/20 | None |
| P11 | 41/m | Yes | 3 to 4 years/unknown | Unknown | Unknown | Disturbance of ellipsoid layer | 6 weeks | Yes | No | 20/32; 20/32 | 20/32; 20/32 | None |
| P12 | 37/m | Yes | Unknown | 2 months | Unknown | Disturbance of ellipsoid layer | None | Unknown | n.a | 20/32 20/32 | n.a. n.a | None |
*VA 4 weeks before PMP RE = 20/40; LE 20/20, upon consultation for PMP no relative afferent pupillary defect, red desaturation or painful ocular motility were detected. In three patients, no information about continuity of ellipsoid zone (EZ) in follow-up was available (n.a. not available)
Fig. 1Quantification of flow deficits (FD) in the CC: A binarized 6 × 6 mm OCTA slab of the superficial capillary plexus with dotted red ring marking the FAZ; B binarized 6 × 6 OCTA slab of CC with a thickness of 20 μm and an offset of 29 μm below the retinal pigment epithelium (RPE). The red ring lines out the projected FAZ to the CC, which is measured as a .5 mm circle for quantification of FDs in CC = Area1, constituting an area of 0.196 mm2 as a standardized FAZ for all evaluated individuals. The remaining Area2 measure the FDs of perifoveolar ring
Fig. 2Quantitative findings of OCTA imaging in poppers maculopathy (PMP) patients (n = 11) compared with age and gender matched healthy controls (n = 11), (A–H). Vessel density (VD, as fraction of area covered by flow signal) of superficial and deep capillary plexus (SCP and DCP) was assessed in binarized OCTA images on the respective plexus (A, C) and visualized in box plots (B, D). No significant change was detected between the two groups. Vessel length density (VLD, mm−1) of SCP and DCP measured on skeletonized images (E, G) of the individual plexus did not show any significant difference between the PMP and the healthy group (F, G)
Fig. 3Resolution of ellipsoid zone-type PMP lesion over the course of 12 weeks in OCT imaging (A–D, F, G). Initial presentation (A, B): note the subfoveal disruption of ellipsoid zone (EZ) and affection of interdigitation zone (IZ). External limiting membrane (ELM) appears continuous but slightly elevated. Similar findings are depicted in 1-week follow-up (C, D). Near infrared en-face imaging (C) demonstrates foveolar hyporeflectivity. After 12 weeks (F, G) sub-foveolar EZ and IZ are assessable as continuous hyperreflective bands but slightly less reflective than the signal of the temporal, nasal continuations of the respective bands. OCTA of superficial capillary plexus of the fovea at weeks 1 and 12 did not show any pathologies (E, H)